This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NovaBay Pharmaceuticals Inc (NBY)

AMEX: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 5.43M 10.50M 12.74M 8.43M
Receivables 273.00K 784.00K 943.00K 3.00K
Inventories 521.00K 231.00K 23.00K 0.00
Other Current Assets 0.00 0.00 445.00K 0.00
Total Current Assets 6.95M 14.79M 18.28M 14.56M
Property, Plant & Equipment, Gross 1.98M 2.37M 2.23M 3.08M
Accumulated Depreciation & Depletion 1.54M 1.65M 1.34M 1.82M
Property, Plant & Equipment, Net 436.00K 718.00K 891.00K 1.27M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 149.00K 141.00K 63.00K 135.00K
Total Non-Current Assets 585.00K 859.00K 954.00K 1.40M
Liabilities & Shareholder Equity
Total Assets 7.54M 15.65M 19.24M 15.96M
Accounts Payable 1.86M 1.67M 455.00K 472.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 3.34M 3.63M 3.17M 2.84M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 171.00K 136.00K 60.00K 0.00
Other Non-Current Liabilities 2.17M 3.37M 1.95M 3.78M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.34M 3.51M 2.01M 3.78M
Total Liabilities 5.69M 7.13M 5.19M 6.62M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.85M 8.52M 14.05M 9.34M
Common Par 516.00K 446.00K 369.00K 286.00K
Additional Paid In Capital 72.88M 64.44M 54.00M 42.39M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -71.55M -56.35M -40.31M -33.28M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 -15.00K -13.00K -44.00K
Total Capitalization 1.85M 8.52M 14.05M 9.34M
Total Equity 1.85M 8.52M 14.05M 9.34M
Total Liabilities & Stock Equity 7.54M 15.65M 19.24M 15.96M
Total Common Shares Outstanding 51.65M 44.62M 36.92M 28.59M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 49.63M 38.18M 29.45M 25.77M
Diluted Weighted Shares Outstanding 49.63M 38.18M 29.45M 25.77M
Number of Employees 32 29 26 27
Number of Part-Time Employees 5 5 4 0
NBY News

NBY NovaBay Pharmaceuticals Inc

Chart of NBY

Analysts Ratings for NBY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

NBY Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs